TeneoTwo
ExitedNew therapy for B-cell hematologic malignancies
TeneoTwo is tracked in the Tech.eu funding database. Based in Delaware, United States; active in Healthtech. Acquired by AstraZeneca in 2022. Data as of Nov 2026.
Delaware, United States
Total raised
—
no tracked rounds
Funding rounds
0
Investors
0
distinct backers
Active since
—
Funding rounds
0 roundsNo funding rounds recorded.
Exit
Type
acquisition
Date
Jul 2022
Value
€1.2B
Acquiror
AstraZeneca (UK)
Related news
- AstraZeneca to Acquire TeneoTwo, For Up To USD1.275 Billionfinsmes.com · 2022-07
Similar companies
same sector, similar size- Sencilia—Netherlands · Healthtech
- Clinithink—UK · Healthtech
- Care—Switzerland · Healthtech
- TimeTeller—Germany · Healthtech
- NeoPrediX—Germany · Healthtech
- Chiron Health AI—UK · Healthtech
Global coverage: FundingData